Abiopharma

🔍 SMITH IAN F (Executive)

Company: Solid Biosciences Inc. (SLDB)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 4,573 shares of Common Stock (Direct)
  Date: 2026-01-06 | Code: M | equity_swap_involved: false | shares_owned_after: 131,264.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 18,012 shares of Stock Option (Right to Buy) at $5.45 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: false | shares_owned_after: 18,012.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 13,761 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-02 | Code: A | equity_swap_involved: false | shares_owned_after: 13,761.00 | transaction_form_type: 4 | Footnotes: F3, F2, F2
• Sold 4,573 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-06 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F4, F4

Footnotes:

• F1: Restricted stock units convert to common stock on a one-for-one basis.
• F2: The Smith RSUs (as defined in footnote 3) and this option (together with the Smith RSUs, the "Smith Equity Awards") were granted on January 2, 2026 ("the Grant Date") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Fourth Amendment to Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full.
• F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "Smith RSUs").
• F4: The restricted stock units were granted on January 6, 2025 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant.